These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29237959)

  • 1. Cardiotoxicity associated with bortezomib: A single-center experience.
    Gurram MK; Pulivarthi S; Ehresmann K; Mathew J
    J Cancer Res Ther; 2017; 13(6):961-963. PubMed ID: 29237959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study.
    Kondo M; Hotta Y; Yamauchi K; Sanagawa A; Komatsu H; Iida S; Kimura K
    BMC Cancer; 2020 Nov; 20(1):1117. PubMed ID: 33203424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of systemic inflammation activity, myocardial structure and functional features, their relationship in patients with multiple myeloma, receiving bortezomib therapy].
    Fomina EV; Kardanova SA; Bochkarnikova OV; Murtuzaliev SM; Appolonova SA; Markin PA; Privalova EV; Ilgisonis IS; Belenkov YN
    Kardiologiia; 2023 Nov; 63(10):29-38. PubMed ID: 37970853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma.
    Iida S; Ichinohe T; Shinagawa A; Suzuki K; Takezako N; Aoki M
    Int J Hematol; 2018 Apr; 107(4):460-467. PubMed ID: 29260507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.
    Chim CS; Kumar SK; Orlowski RZ; Cook G; Richardson PG; Gertz MA; Giralt S; Mateos MV; Leleu X; Anderson KC
    Leukemia; 2018 Feb; 32(2):252-262. PubMed ID: 29257139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triplet vs. doublet drug regimens for managing multiple myeloma.
    Offidani M; Corvatta L; Gentili S
    Expert Opin Pharmacother; 2018 Feb; 19(2):137-149. PubMed ID: 29265901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront treatment of elderly myeloma patients: an overview and update.
    Elsayed HG; Alabdulwahab AS
    Expert Rev Hematol; 2018 Feb; 11(2):99-108. PubMed ID: 29260588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma.
    Bringhen S; D'Agostino M; De Paoli L; Montefusco V; Liberati AM; Galieni P; Grammatico S; Muccio VE; Esma F; De Angelis C; Musto P; Ballanti S; Offidani M; Petrucci MT; Gaidano G; Corradini P; Palumbo A; Sonneveld P; Boccadoro M
    Leukemia; 2018 Apr; 32(4):979-985. PubMed ID: 29263440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Plasmapheresis in the Management of Acute Kidney Injury in Patients With Multiple Myeloma: Should We Abandon It?
    Premuzic V; Batinic J; Roncevic P; Basic-Jukic N; Nemet D; Jelakovic B
    Ther Apher Dial; 2018 Feb; 22(1):79-86. PubMed ID: 29239143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.
    Tsakiri EN; Terpos E; Papanagnou ED; Kastritis E; Brieudes V; Halabalaki M; Bagratuni T; Florea BI; Overkleeft HS; Scorrano L; Skaltsounis AL; Dimopoulos MA; Trougakos IP
    Sci Rep; 2017 Dec; 7(1):17802. PubMed ID: 29259189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.
    Ludwig H; Delforge M; Facon T; Einsele H; Gay F; Moreau P; Avet-Loiseau H; Boccadoro M; Hajek R; Mohty M; Cavo M; Dimopoulos MA; San-Miguel JF; Terpos E; Zweegman S; Garderet L; Mateos MV; Cook G; Leleu X; Goldschmidt H; Jackson G; Kaiser M; Weisel K; van de Donk NWCJ; Waage A; Beksac M; Mellqvist UH; Engelhardt M; Caers J; Driessen C; Sonneveld P
    Leukemia; 2017 Dec; ():. PubMed ID: 29251284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daratumumab for untreated multiple myeloma.
    Stirrups R
    Lancet Oncol; 2018 Feb; 19(2):e80. PubMed ID: 29276025
    [No Abstract]   [Full Text] [Related]  

  • 13. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
    Kumar SK; Dispenzieri A; Fraser R; Mingwei F; Akpek G; Cornell R; Kharfan-Dabaja M; Freytes C; Hashmi S; Hildebrandt G; Holmberg L; Kyle R; Lazarus H; Lee C; Mikhael J; Nishihori T; Tay J; Usmani S; Vesole D; Vij R; Wirk B; Krishnan A; Gasparetto C; Mark T; Nieto Y; Hari P; D'Souza A
    Leukemia; 2018 Apr; 32(4):986-995. PubMed ID: 29263438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literature.
    Shaulov A; Avivi I; Cohen Y; Duek A; Leiba M; Gatt ME
    Amyloid; 2018 Mar; 25(1):11-17. PubMed ID: 29241368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falls in older adults with multiple myeloma.
    Wildes TM; Fiala MA
    Eur J Haematol; 2018 Mar; 100(3):273-278. PubMed ID: 29239009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the Choriocapillaris Layer in Optical Coherence Tomography Angiography of Acute Central Serous Chorioretinopathy.
    Qu Y; Gong D; Yu W; Dong F
    Ophthalmic Surg Lasers Imaging Retina; 2017 Dec; 48(12):1000-1005. PubMed ID: 29253303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2.
    Qu Y; Zhang H; Sun W; Han Y; Li S; Qu Y; Ying G; Ba Y
    Cancer Sci; 2018 Mar; 109(3):618-628. PubMed ID: 29247570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
    Saji H; Ueno T; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Ito H; Kataoka K; Okabe K; Tomizawa K; Yoshimoto K; Horio H; Sugio K; Ode Y; Takao M; Okada M; Chida M;
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):835-841. PubMed ID: 29240884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to nitrogen dioxide (NO2) and respiratory disease risk.
    Chauhan AJ; Krishna MT; Frew AJ; Holgate ST
    Rev Environ Health; 1998; 13(1-2):73-90. PubMed ID: 9718623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picro-thionin (Schmorl) staining of bone and other hard tissues.
    Allison RT
    Br J Biomed Sci; 1995 Jun; 52(2):162-4. PubMed ID: 8520253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.